Skip to main content

P-002 Pill - blue round, 11mm

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate

Pill with imprint P-002 is Blue, Round and has been identified as Urelle hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Pharmelle LLC.

Urelle is used in the treatment of Urinary Tract Infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Urelle hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for P-002

Urelle hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg P-002

Urelle

Generic Name
hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Imprint
P-002
Strength
hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg
Color
Blue
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pharmelle LLC
National Drug Code (NDC)
66663-0219 (Discontinued)
Inactive Ingredients
corn starch, calcium phosphate dibasic anhydrous, FD&C Blue No. 2, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "P-002"

More about Urelle (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Patient resources

Other brands

Uribel, Uro-MP, Uretron DS, Ustell, ... +15 more

Professional resources

Other brands

Uribel, Uretron DS, Phosphasal, Urimar-T, ... +6 more

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.